Focused on novel, nanotechnology-based therapeutics
Oliver Fetzer, Ph.D.
President and Chief Executive Officer
David P. DeMagistris, Ph.D.
Senior Vice President, Pharmaceutical Sciences and Manufacturing
David brings to Cerulean over twenty-five years of drug development experience. He joined Cerulean from GlaxoSmithKline (GSK), where he held positions of increasing responsibility in pharmaceutical development, licensing and drug delivery. From 2003-2008, he led the Global Strategic Technologies group at GSK responsible for drug delivery, particle engineering, and innovative product and process development.
David earned his B.S. in Pharmacy from Albany College of Pharmacy and his Ph.D. in Industrial and Physical Pharmacy from Purdue University.
Scott Eliasof, Ph.D.
Senior Director, Research
Alexandra Glucksmann, Ph.D.
Senior Vice President, Research and Business Operations
Senior Vice President, Finance and Administration
John Ryan, Ph.D., M.D.
Senior Vice President and Chief Medical Officer
Jean Silveri, J.D.
Senior Vice President, General Counsel
Senior Director, Pharmaceutical Sciences and Manufacturing
Cissy Young, Ph.D.
Director, Strategy and Business Development